Advertisement

Basal Cell Adenoma

  • Joaquín J. García
Chapter

Abstract

Basal cell adenoma is the benign counterpart of basal cell adenocarcinoma. Basal cell adenoma affects primarily adults and presents at a mean age of approximately 65 years. Women are involved slightly more than men. The majority of cases involve the parotid gland, presenting as single or multiple masses. Basal cell adenoma may be well-circumscribed or multinodular, comprised of multiple cell types (ductal and basal), and exhibit a variety of architectural patterns (solid, trabecular, tubular, and membranous) (Figs. 8.1, 8.2, 8.3, 8.4, 8.5, 8.6, 8.7, 8.8, 8.9, 8.10, 8.11, 8.12, 8.13, 8.14, 8.15, 8.16, 8.17, 8.18, 8.17, 8.18, 8.18, 8.19, 8.20, 8.21, 8.22, 8.23, 8.24, 8.24, 8.25, 8.26, 8.27 and 8.28).

Keywords

Monomorphic adenoma Basaloid salivary gland adenoma 

Suggested Reading

  1. Bastakis JG, Luna MA, el-Naggar AK. Basaloid monorphic adenomas. Ann Otol Rhinol Laryngol. 1991;100:687–90.CrossRefGoogle Scholar
  2. Chhieng DC, Paulino AF. Basaloid tumors of the salivary glands. Ann Diagn Pathol. 2002;6(6):364–72.CrossRefGoogle Scholar
  3. Edwards PC, Bhuiya T, Kelsch RD. Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;97(5):613–9.CrossRefGoogle Scholar
  4. Ethunandan M, Pratt CA, Macpherson DW. Changing frequency of parotid gland neoplasms—analysis of 560 tumors treated in a district general hospital. Ann R Coll Surg Engl. 2002;84:1–6.PubMedPubMedCentralGoogle Scholar
  5. Hyman BA, Scheithauer BW, Weiland LH, Irons GB. Membranous basal cell adenoma of the parotid gland. Malignant transformation in a patient with multiple dermal cylindromas. Arch Pathol Lab Med. 1988;112:209–11.PubMedPubMedCentralGoogle Scholar
  6. Klijanienko J, El-Naggar AK, Vielh P. Comparative cytologic and histologic study of fifteen salivary basal-cell tumors: differential diagnostic considerations. Diagn Cytopathol. 1999;21(1):30–4.CrossRefGoogle Scholar
  7. Machado de Sousa SO, Soares de Araújo N, Corrêa L, Pires Soubhia AM, Cavalcanti de Araújo V. Immunohistochemical aspects of basal cell adenoma and canalicular adenoma of salivary glands. Oral Oncol. 2001;37(4):365–8.CrossRefGoogle Scholar
  8. Nagao T, Sugano I, Ishida Y, Hasegawa M, Matsuzaki O, Konno A, et al. Basal cell adenocarcinoma of the salivary glands: comparison with basal cell adenoma through assessment of cell proliferation, apoptosis, and expression of p53 and bcl-2. Cancer. 1998;82(3):439–47.CrossRefGoogle Scholar
  9. Scott AR, Faquin WC, Deschler DG. Parotid mass in a woman with multiple cutaneous cylindromas. Head Neck. 2010;32:684–7.CrossRefGoogle Scholar
  10. Tian Z, Li L, Wang L, Hu Y, Li J. Salivary gland neoplasms in oral and maxillofacial regions: a 23-year retrospective study of 6982 case in an eastern Chinese population. Int J Oral Maxillofac Surg. 2010;39:235–42.CrossRefGoogle Scholar
  11. Wilson TC, Robinson RA. Basal cell adenocarcinoma and basal cell adenoma of the salivary glands: a clinicopathological review of seventy tumors with comparison of morphologic features and growth control indices. Head Neck Pathol. 2015;9:205–13.CrossRefGoogle Scholar
  12. Yu GY, Ubmüller J, Donath K. Membranous basal cell adenoma of the salivary gland: a clinicopathologic study of 12 cases. Acta Otolaryngol. 1998;118:588–93.CrossRefGoogle Scholar
  13. Zarbo RJ, Prasad AR, Regezi JA, Gown AM, Savera AT. Salivary gland basal cell and canalicular adenomas: immunohistochemical demonstration of myoepithelial cell participation and morphogenetic considerations. Arch Pathol Lab Med. 2000;124(3):401–5.PubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2019

Authors and Affiliations

  • Joaquín J. García
    • 1
  1. 1.Mayo Clinic School of Medicine, Department of Laboratory Medicine & PathologyMayo Clinic RochesterRochesterUSA

Personalised recommendations